Abingdon Health (LON:ABDX) Reaches New 1-Year High – Here’s What Happened

Abingdon Health Plc (LON:ABDX)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 11 and last traded at GBX 10.49, with a volume of 1225858 shares trading hands. The stock had previously closed at GBX 10.50.

Abingdon Health Price Performance

The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The stock’s 50 day moving average price is GBX 7.56 and its two-hundred day moving average price is GBX 6.88. The firm has a market capitalization of £26.33 million, a price-to-earnings ratio of -12.95 and a beta of 0.25.

Abingdon Health (LON:ABDX) last announced its earnings results on Tuesday, March 17th. The company reported GBX (0.43) EPS for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.